{"transactions":[{"id":741224,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-11T20:30:12.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":2412,"price":7.9137,"value":19087.8444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":7579,"source":{"system":"sec-edgar","filing":"0001193125-26-267655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526267655/ownership.xml","form_type":"4"}},{"id":767481,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:05:51.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234851","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234851/ownership.xml","form_type":"4"}},{"id":767480,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:05:51.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":9991,"source":{"system":"sec-edgar","filing":"0001193125-26-234851","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234851/ownership.xml","form_type":"4"}},{"id":1015153,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":1060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":4247,"derivative":{"exercise_price":4.8,"expiration_date":"2032-09-26","underlying":"Common Stock","underlying_shares":1060},"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1015152,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":1060,"price":20.5,"value":21730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant."}],"balance_after":6191,"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1015151,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":1060,"price":4.8,"value":5088.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1127195,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1127194,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":6191,"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1127193,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":1392,"price":7.2526,"value":10095.6192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.16 to $7.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1391,"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1494776,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-03T20:26:50.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"source":{"system":"sec-edgar","filing":"0000950170-24-068005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024068005/ownership.xml","form_type":"4"}},{"id":1508574,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-20T20:53:11.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"derivative":{"exercise_price":45.92,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":2783},"source":{"system":"sec-edgar","filing":"0001209191-24-005670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124005670/doc4.xml","form_type":"4"}},{"id":1882156,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:33:59.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest 100% on the one year anniversay from the date of grant."}],"balance_after":5300,"derivative":{"exercise_price":9.96,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-23-031474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919123031474/doc4.xml","form_type":"4"}},{"id":2149791,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2022-09-28T13:38:09.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":159200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":159200,"derivative":{"exercise_price":0.16,"expiration_date":"2022-09-26","underlying":"Common Stock","underlying_shares":159200},"source":{"system":"sec-edgar","filing":"0001209191-22-051425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122051425/doc4.xml","form_type":"4"}}]}